Mounjaro 2.5 mg

Mounjaro 2.5 mg is a prescription, once-weekly treatment designed for adults living with type 2 diabetes and those requiring structured medical support for weight management. The mounjaro 2.5 mg injection delivers tirzepatide through the convenient use the once-weekly Mounjaro® pen, making it simple to administer at home. Tirzepatide injection is used to treat type 2 diabetes. It works as a dual GIP and GLP-1 receptor agonist, helping to regulate blood glucose levels while also supporting appetite control and metabolic function. In clinical settings, Mounjaro 2.5 mg weight loss benefits have been observed alongside improved glycaemic control, as it is a non-insulin injection for adults that enhances the body’s natural hormonal response to food intake. Patients considering mounjaro 2.5 mg uk prescriptions should consult a qualified healthcare professional to determine suitability, dosage titration, and monitoring requirements for safe and effective therapy.